Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 7,493,552 |
|
|||||
| News | - | ||||||
| Day High | 128.10 | Low High |
|||||
| Day Low | 126.74 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.1892 | -0.15% | 126.7508 | 16:36:46 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 128.08 | 126.74 | 128.10 | 126.88 | 126.94 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 80,175 | 7,493,552 | $ 127.36 | $ 954,390,023 | - | 99.14 - 133.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:41:46 | 1 | $ 126.97 | USD |
Merck (MRK) Options Flow Summary
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 321.34B | 2.53B | - | 60.12B | 365M | 0.14 | 880.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 126.005 | 128.10 | 124.50 | 125.76 | 6,913,883 | 0.7458 | 0.59% |
| 1 Month | 125.78 | 133.10 | 124.50 | 127.88 | 7,244,809 | 0.9708 | 0.77% |
| 3 Months | 121.20 | 133.10 | 119.41 | 125.40 | 8,349,642 | 5.55 | 4.58% |
| 6 Months | 102.90 | 133.10 | 99.80 | 116.01 | 8,358,876 | 23.85 | 23.18% |
| 1 Year | 115.85 | 133.10 | 99.14 | 112.95 | 7,691,172 | 10.90 | 9.41% |
| 3 Years | 77.85 | 133.10 | 70.89 | 93.28 | 9,979,369 | 48.90 | 62.81% |
| 5 Years | 73.70 | 133.10 | 65.25 | 88.20 | 9,987,179 | 53.05 | 71.98% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. |
